tiprankstipranks
Chong Kun Dang Pharmaceutical Corp. (KR:185750)
:185750
South Korea Market
185750
Chong Kun Dang Pharmaceutical Corp.
RESEARCH TOOLSreports

Chong Kun Dang Pharmaceutical Corp. (185750) Financial Statements

1 Followers

Chong Kun Dang Pharmaceutical Corp. Financial Overview

Chong Kun Dang Pharmaceutical Corp.'s market cap is currently ₩880.16B. The company's EPS TTM is $6031.21; its P/E ratio is 11.08; and it has a dividend yield of 0.75%. Chong Kun Dang Pharmaceutical Corp. is scheduled to report earnings on August 14, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₩ 1.69T₩ 1.59T₩ 1.67T₩ 1.49T₩ 1.34T
Gross Profit₩ 517.23B₩ 532.61B₩ 662.20B₩ 542.64B₩ 495.82B
Operating Income₩ 80.57B₩ 99.46B₩ 246.60B₩ 109.91B₩ 94.76B
EBITDA₩ 125.37B₩ 150.03B₩ 287.62B₩ 137.52B₩ 112.61B
Net Income₩ 77.83B₩ 109.07B₩ 212.52B₩ 80.95B₩ 42.72B
Balance Sheet
Cash & Short-Term Investments₩ 346.50B₩ 302.17B₩ 365.07B₩ 155.86B₩ 187.33B
Total Assets₩ 1.80T₩ 1.46T₩ 1.40T₩ 1.12T₩ 1.05T
Total Debt₩ 367.76B₩ 188.15B₩ 219.76B₩ 235.74B₩ 237.05B
Net Debt₩ 151.52B₩ -40.32B₩ 117.53M₩ 118.32B₩ 105.24B
Total Liabilities₩ 793.94B₩ 562.39B₩ 586.79B₩ 503.59B₩ 480.89B
Stockholders' Equity₩ 1.00T₩ 893.97B₩ 815.69B₩ 622.39B₩ 566.01B
Cash Flow
Free Cash Flow₩ -73.49B₩ -1.81B₩ 249.35B₩ 14.67B₩ -38.94B
Operating Cash Flow₩ 67.36B₩ 64.29B₩ 318.16B₩ 67.73B₩ 12.90B
Investing Cash Flow₩ -245.28B₩ 3.73B₩ -171.31B₩ -65.38B₩ -90.81B
Financing Cash Flow₩ 166.96B₩ -63.11B₩ -43.70B₩ -16.34B₩ 85.14B
Currency in KRW

Chong Kun Dang Pharmaceutical Corp. Earnings and Revenue History

Income Statement >

Chong Kun Dang Pharmaceutical Corp. Debt to Assets

Balance Sheet >

Chong Kun Dang Pharmaceutical Corp. Cash Flow

Cash Flow >

Chong Kun Dang Pharmaceutical Corp. Forecast EPS vs Actual EPS

Earnings >